Adrafinil

From WikiMD.org
Jump to navigation Jump to search

Adrafinil

Adrafinil (/ædrəˈfɪnɪl/; brand name Olmifon) is a eugeroic that was formerly used in France to promote alertness, attention, wakefulness, mood, and other parameters, particularly in the elderly. It was also used off-label by individuals who wished to avoid fatigue, such as night workers or others who needed to stay awake and alert for long periods of time.

Etymology

The term "Adrafinil" is derived from the French words "adra-", meaning "alertness", and "-finil", which is a common ending for pharmaceuticals that affect the central nervous system.

Pharmacology

Adrafinil is a prodrug; it is primarily metabolized in vivo to modafinil, resulting in nearly identical pharmacological effects. Unlike modafinil, however, it takes time for the metabolite to accumulate to active levels in the bloodstream. Effects usually are apparent within 45–60 minutes when taken orally on an empty stomach.

Side Effects

Side effects are rare with adrafinil and are generally mild. They can include insomnia, headache, stomach pain, nausea, heart palpitations, and dizziness. In some cases, these side effects can be severe enough to warrant discontinuation of treatment.

Legal Status

Adrafinil is unregulated in the United States, Canada, and the United Kingdom. In some countries, such as Australia, it is classified as a Schedule 4 (prescription only) drug.

See Also

References


External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski